Sergio Cedillo

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 06, 2023
Cost-effectiveness of olaparib plus bevacizumab versus bevacizumab monotherapy in the maintenance of patients with homologous recombination deficiency-positive advanced ovarian cancer after response to first-line platinum-based chemotherapy.

Sergio Cedillo, Carla Garí, Susana Aceituno

Pageof 1

Frequent Collaborators

1 joint publications

Alejandro Perez Fidalgo